WELCOME to HIV-NAT!
The HIV Netherlands Australia Thailand Research Collaboration. HIVNAT is affiliated with The Thai Red Cross AIDS Research Centre in Bangkok, Thailand, with the Kirby Institute for infection and immunity in society in Sydney, Australia, and with the Amsterdam Institute for Global Health and Development in Amsterdam, The Netherlands. Since 1996 our centre has been conducting clinical research in HIV, meeting international standards, and gaining vast experience in the coordination of multicentre trials in Thailand.
Follow us on:
May 15, 2013
The HIV Netherlands Australia Thailand Research Collaboration (HIV-NAT) is the largest international HIV clinical research unit within the Thai Red Cr ... Read More
March 19, 2013
In 2012, HIV-NAT Research Laboratory received the Thailand Biorisk Management Champion Award for its excellent management of Biosafety level 2 in clin ... Read More
March 19, 2013
The Children and Youth Program of the Thai Red Cross AIDS Research Centre was bestowed ‘Tara Award’ from Sathien Dhamma Sathan on 31 October 2012. ... Read More
March 18, 2013
Conference on Retroviruses and Opportunistic Infections (CROI 2013); Paper #47: Early ART Intervention Restricts the Seeding of the HIV Reservoir in L ... Read More
September 4, 2012
The HIV Netherlands Australia Thailand Research Collaboration (HIV-NAT), a sub-unit of the Thai Red Cross AIDS Research Centre officially launc ... Read More
HIV-NAT Conferences & Trainings
One of the best HIV medicine conferences in Asia Pacific, the Bangkok International Symposium brings together experts in the HIV field from all over the world. The next Symposium will take place from 16-18 January 2013.
Scheduled to take place twice a year, the Symposium Series training workshops are centered on care management and treatment for people living with HIV/AIDS. The purpose of the training workshop is to provide in-depth knowledge on HIV care and treatment to medical doctors, nurses, pharmacists and healthcare practitioners. The training workshops are conducted in Thai.
One of the leading causes of death among people living with HIV, tuberculosis remains a serious threat for HIV-infected people. Antiretroviral drugs ... Read More
- 'Early versus deferred antiretroviral therapy for children older than 1 year infected with HIV (PREDICT): a multicentre, randomised, open-label trial' was published in The Lancet Infectious Diseases journal on 9 October 2012.
- Immunologic and virologic failure after first-line highly active antiretroviral therapy in HIV-infected children.
- Neither branded nor generic lopinavir/ritonavir produces adequate lopinavir concentrations at a reduced dose of 200/50 mg BID.
- Factors associated with elevated ALT in an international HIV/HBV co-infected cohort on long-term HAART.
Jan 15-17, 2014
17th Bangkok International Symposium on HIV Medicine
July 25-26, 2013
March 22, 2013
Building Provincial Capacity to Treat HCV Workshop at Khonkaen Hospita;, Khon Kaen Province
Jan 16-18, 2013
Mar 26-28, 2012
Feb 13-15, 2012
Feb 27-28, 2012
© Copyright 2012 HIV-NAT. All Rights Reserved.
The HIV Netherlands Australia Thailand Research Collaboration